Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Iris L. van Staveren
TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients With Recurrent Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy
Breast Cancer Research and Treatment
Cancer Research
Oncology
T Cells Predict Outcome in Zoledronate-Treated Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
A Polymorphism in the TC21 Promoter Associates With an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer
Cancer Research
Cancer Research
Oncology
E-Cadherin Genetic Variants Predict Survival Outcome in Breast Cancer Patients
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Tamoxifen and Mastectomy for Elderly Patients With Operable Breast Cancer.
BMJ
C–X–C Ligand 10 and C–X–C Receptor 3 Status Can Predict Tamoxifen Treatment Response in Breast Cancer Patients
Breast Cancer Research and Treatment
Cancer Research
Oncology
Differentially Expressed Genes Between Primary Cancer and Paired Lymph Node Metastases Predict Clinical Outcome of Node-Positive Breast Cancer Patients
Breast Cancer Research and Treatment
Cancer Research
Oncology
Risk of Endometrial Cancer After Tamoxifen Treatment of Breast Cancer
The Lancet
Medicine
MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
